Metraipolis › archive › dc_beaaa0425dee

Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination — Europe PMC PMID:42274605

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42274605
DOI
10.3390/cells15111012
License (as archived)
solo-consultazione
Archived
2026-11-01T02:11:01.666Z
SHA-256 of the archived text
7702e47729705228aa187a55b1723572e76a3be4c58abb40d55cc9a48a8911b5
Stable URL of this page
https://metraipolis.com/documento/dc_beaaa0425dee

How to cite

Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination — Europe PMC PMID:42274605 — Europe PMC (en), https://europepmc.org/article/MED/42274605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beaaa0425dee (Metraipolis archive dc_beaaa0425dee, sha256 7702e47729705228aa187a55b1723572e76a3be4c58abb40d55cc9a48a8911b5)
BibTeX
@misc{dcbeaaa0425dee,
  title = {Pharmacological Targeting of PI3K/Akt/mTOR and Wnt/GSK-3β Signaling in Oligodendrocyte Differentiation and Remyelination — Europe PMC PMID:42274605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42274605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beaaa0425dee; sha256 7702e47729705228aa187a55b1723572e76a3be4c58abb40d55cc9a48a8911b5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42274605. Agents can read the archived copy with the MCP tool read_document.